✦ LIBER ✦

Pelvic fibromatosis (desmoid) — treatment with steroids and tamoxifen

✍ Scribed by A. Mukherjee; A. Malcolm; M. De La Hunt; D.E. NealMS

Book ID: 115197857
Publisher: John Wiley and Sons
Year: 1995
Tongue: English
Weight: 249 KB
Volume: 75
Category: Article
ISSN: 1464-4096
DOI: 10.1111/j.1464-410x.1995.tb07289.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fibromatosis, desmoids, fibroblasts, and

Fibromatosis, desmoids, fibroblasts, and tamoxifen

✍ M.J. Timmons 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 348 KB

A recurrent pelvic desmoid tumor success

A recurrent pelvic desmoid tumor successfully treated with tamoxifen

✍ Debora J. Sportiello; David L. Hoogerland 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 488 KB 👁 2 views

TREATMENT OF RECURRENT DESMOID TUMOUR WI

TREATMENT OF RECURRENT DESMOID TUMOUR WITH TAMOXIFEN

✍ Shaji Thomas; Siddhartha Datta-Gupta; Brij M. L. Kapur 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 386 KB

Regression of large pelvic desmoid tumor

Regression of large pelvic desmoid tumor by tamoxifen and sulindac

✍ Joseph K. Izes; Leonard N. Zinman; Carl R. Larsen 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 911 KB

High-dose tamoxifen and sulindac as firs

High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors

✍ Anika Hansmann; Claudia Adolph; Tilmann Vogel; Andreas Unger; Gabriela Moeslein 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

## Abstract ## BACKGROUND Desmoid tumors are mesenchymal nonmetastasizing neoplasms. Although rare in the general population, they are a common extracolonic manifestation of familial adenomatous polyposis (FAP). Because of high tumor recurrence rates, surgery has been less than satisfactory in the

High-dose tamoxifen and sulindac as firs

High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors

✍ N. Julian H. Sturt; Robin K. S. Phillips; Susan K. Clark 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

tional RCC and extensively cystic Bosniak Grade 2 or 3 disease, which may be difficult to diagnose reliably using either fine-needle or core-needle biopsy. Correlation of the results presented by Volpe et al. with the additional findings discussed in the current correspondence may be useful.